Overview

QR052107B Tablets in Patients With Subacute Cough of Phase Study

Status:
COMPLETED
Trial end date:
2023-12-25
Target enrollment:
Participant gender:
Summary
The purpose of the study is to Evaluate the Efficacy and Safety of QR052107B 100mg QR052107B 400mg in Patients with Subacute Cough.
Phase:
PHASE2
Details
Lead Sponsor:
Wuhan Createrna Science and Technology Co., Ltd